Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 77

Results For "SMA"

903 News Found

Merck’s tepmetko receives positive CHMP opinion in Europe
Biotech | December 20, 2021

Merck’s tepmetko receives positive CHMP opinion in Europe

The medicine is the first and only oral MET inhibitor to receive CHMP positive opinion in Europe for adult patients with advanced NSCLC harbouring alterations leading to METex14 skipping


Dr. Azad Moopen proposes two health schemes for low-income NRIs to Union Minister Dr Mansukh Mandaviya
Public Health | December 16, 2021

Dr. Azad Moopen proposes two health schemes for low-income NRIs to Union Minister Dr Mansukh Mandaviya

The proposed scheme to include low-income NRIs under Ayushman Bharat (PM-JAY) would ensure life-long coverage for each individual along with their spouses


U.S. FDA approves Bristol Myers Squibb’s Orencia
Drug Approval | December 16, 2021

U.S. FDA approves Bristol Myers Squibb’s Orencia

Orencia is the first FDA-approved therapy to prevent acute graft versus host disease following hematopoietic stem cell transplant


Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA
News | December 15, 2021

Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA

During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests


Philips set to acquire Vesper Medical
Medical Device | December 14, 2021

Philips set to acquire Vesper Medical

Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease


Kaka-Ba hospital surgeons perform surgery to correct spine disorder
Hospitals | December 13, 2021

Kaka-Ba hospital surgeons perform surgery to correct spine disorder

Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.


Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia
Biotech | December 13, 2021

Zydus to begin Phase II (a) clinical trial of ZYIL1 in Australia

It is a novel oral NLRP3 inflammasome inhibitor


Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials
Biotech | December 10, 2021

Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials

Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants


Cytel and Pulse Infoframe to transform rare disease research landscape
Biotech | December 10, 2021

Cytel and Pulse Infoframe to transform rare disease research landscape

Both companies will combine their expertise to channel real-world evidence toward ground-breaking new treatments in rare diseases


Aerogen partners with CanSinoBIO for aerosolised Covid-19 vaccine
Biotech | December 10, 2021

Aerogen partners with CanSinoBIO for aerosolised Covid-19 vaccine

The interim results of Phase 3 clinical trials conducted by CanSinoBIO demonstrated that Convidecia has an efficacy of 95.47% at preventing severe disease 14 days after single-dose vaccination.